Clinical Trial Update: Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification [NA]

View source ↗

Summary

A completed clinical trial evaluating whether altering dietary macronutrient intake can disrupt cancer metabolism and growth in ovarian and endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Ovarian Cancer, Endometrial Cancer | NA | Status: COMPLETED